Smart Money Bets on Value | Predictions for 2025

My big prediction for 2025 is that value will play an increasingly important role in healthcare conversations. One place this will play out is in conversations about the Medicare Prescription Drug Negotiation Program. They will center not only around the unintended consequences of the program for patients but also about whether CMS is thinking about value as [it implements] the program and particularly as CMS releases the concise justifications for the first round of set prices.

What evidence they say they considered may impact the incentives for generating value-related, real-world evidence in the future. Another area is that researchers will continue to explore and develop alternative methods that seek to better incorporate the full spectrum of value.

Finally, employers will continue to consider value as they select pharmacy benefits. Data from this year show that those with value-based formularies saved three times as much as those with rebate-based agreements.